OMICS Group invites all the participants across the globe to attend the 2nd International Conference and Exhibition on Biowaivers and Biosimilars during September 23-25, 2013 Hilton, Raleigh, North Carolina, USA.

20% exclusively discount for ChemLinked members to register the event

The patent expirations of generics have given a gateway to Biosimilars into the Global Pharmaceutical Economy since last few years. Though the regulatory prospects upon Follow-on Biologics were not much implemented in past years, the present circumstances of pharmaceutical R&Ds are worried about patent issues with generic drugs and their molecular entities.

The criteria required in filing of biological drugs will be discussed by popular agencies and their representatives in this meeting. Biosimilars trials and special case reports will be presented to denote the purpose and clinical data requirements for the future growth of Biosimilars and Biowaivers.

Biosimilars-2013 will provide an excellent and global opportunity to the scientists, partners and pharma leaders from Biopharmaceutical and Biotechnology industries to innovate and to explore the strategic market for Biosimilars and Biowaivers.

Conference Highlights:

Challenges and Regulatory Approach for Biosimilars
Emerging Biosimilars in Therapeutics
Clinical Studies and Clinicians Prospects for Biosimilars
Globalization of Biosimilars
Biosimilars Innovator Pharmaceutical Products
Analytical Strategies
Bioequivalence Assessment
BCS & IVIVC Based Biowaivers
Plant Produced Biosimilar Products